Jennifer Lopez voltou a incendiar as redes sociais com uma publicação no Instagram fazendo referência à série "Bridgerton".

O Sul do Brasil é um destino encantador para os amantes de vinho e boa gastronomia. Repleto de vinícolas premiadas, paisagens deslumbrantes e ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Syringes with needles are seen in front of a displayed Moderna logo in this illustration taken, November 27, 2021.

What To Know: Moderna said it expects 2025 revenue of approximately $1.9 billion, which is $100 million above the midpoint previously communicated during its third-quarter earnings call. The company ...

Initiate Moderna with a Hold rating at a $25 target price (lower than the current price), citing balanced risk-reward despite the advanced mRNA platform and robust pipeline. MRNA's near-term execution ...

Moderna has rallied ~23%, but I maintain a 'Sell' and 'market underperform' rating due to deteriorating fundamentals. MRNA’s recent rally is driven by improved liquidity, cost discipline, and a $1.5 ...

Dec 18 (Reuters) - Moderna (MRNA.O), opens new tab will get up to $54.3 million in funding from a global coalition to support late-stage development of its experimental bird flu vaccine, the U.S.

Moderna announced Thursday it will receive up to $54.3 million from a global vaccine partnership to fund its ongoing research into a potential bird flu mRNA vaccine, helping to recover some of the ...

Moderna has tapped Swedish long-acting drug formulation company Nanexa to improve the delivery of up to five injectable therapies. The heavily back-loaded deal will see Moderna hand over just $3 ...

Here's your look at the Zlín City: Arch Moderna announcement trailer for this upcoming cozy, historically inspired city-builder. Join developer Polyperfect for a behind-the-scenes look at the creation ...

The federal agency has not publicized how it reached its conclusions. The top vaccine chief at the Food and Drug Administration sent out a memo saying the FDA will seek a stricter review and approval ...

Moderna, an mRNA specialist known for its COVID-19 vaccine Spikevax, is winding down development of three clinical mRNA programs, including two investigational vaccines for infectious diseases. The ...